Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma.
Limaye S, Patil D, Akolkar D, Srivastava N, Patil R, Apurwa S, Patil S, John J, Gosavi R, Nesargikar P, Kumar P, Datta V, Bose C, Raazi Z, Srinivasan A, Datar R.
Limaye S, et al. Among authors: kumar p.
Clin Case Rep. 2021 Nov 7;9(11):e04986. doi: 10.1002/ccr3.4986. eCollection 2021 Nov.
Clin Case Rep. 2021.
PMID: 34765202
Free PMC article.